{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T03:07:15Z","timestamp":1776827235678,"version":"3.51.2"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":819,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.5604\/16652681.1231585","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T11:18:30Z","timestamp":1487848710000},"page":"247-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B\/C of Hepatocellular Carcinoma: A Single Centre Experience"],"prefix":"10.1016","volume":"16","author":[{"given":"Joy","family":"Varghese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandan Kumar","family":"Kedarisetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayanthi","family":"Venkataraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijaya","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiruchunapalli","family":"Deepashree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mangerira Chinnappa","family":"Uthappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaliamurthy","family":"Ilankumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Govil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mettu","family":"Srinivas Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Rela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.5604\/16652681.1231585_bib0005","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBO-CAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.5604\/16652681.1231585_bib0010","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2036.2010.04370.x","article-title":"Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection","volume":"32","author":"Alazawi","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.5604\/16652681.1231585_bib0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1568009053202063","article-title":"Treatment modalities for hepatocellular carcinoma","volume":"5","author":"Hung","year":"2005","journal-title":"Curr Cancer Drug Targets"},{"key":"10.5604\/16652681.1231585_bib0020","first-page":"S115","volume":"10","author":"Llovet","year":"2004","journal-title":"The Barcelona Approach: Diagnosis, Staging, and Treatment of Hepatocellular Carcinoma Liver Transplantation"},{"key":"10.5604\/16652681.1231585_bib0025","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.3748\/wjg.v20.i15.4115","article-title":"Hepatocellular carcinoma review: Current treatment, and evidence-based medicine","volume":"20","author":"Raza","year":"2014","journal-title":"World J Gastro-enterol"},{"key":"10.5604\/16652681.1231585_bib0030","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hep.22412","article-title":"Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis","volume":"48","author":"Yao","year":"2008","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1231585_bib0035","first-page":"450","article-title":"Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: a retrospective analysis","volume":"5","author":"Dong","year":"2014","journal-title":"Am J Cancer Res"},{"key":"10.5604\/16652681.1231585_bib0040","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellu-lar carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.5604\/16652681.1231585_bib0045","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1572-0241.2007.01712.x","article-title":"Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angio-genesis and invasiveness","volume":"103","author":"Sergio","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.5604\/16652681.1231585_bib0050","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.5604\/16652681.1231585_bib0055","doi-asserted-by":"crossref","first-page":"e100305","DOI":"10.1371\/journal.pone.0100305","article-title":"Transarterial chemo-embolization (TACE) plus sorefanib versus TACE for Intermediate or Advanced Stage Hepatocellular carcinoma: A meta-analysis","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.5604\/16652681.1231585_bib0060","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","article-title":"Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3 randomised, double-blind, placebo controlled trial","volume":"16","author":"Bruix","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.5604\/16652681.1231585_bib0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cgh.2010.09.017","article-title":"CT and MRI improve detection of hepatocel-lular carcinoma, compared with ultrasound alone, in patients with cirrhosis","volume":"9","author":"Yu","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.5604\/16652681.1231585_bib0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.5604\/16652681.1231585_bib0075","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ctrv.2010.07.006","article-title":"Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization","volume":"37","author":"Raoul","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.5604\/16652681.1231585_bib0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003495-200969020-00006","article-title":"Sorafenib: a review of its use in advanced hepatocellular carcinoma","volume":"69","author":"Keating","year":"2009","journal-title":"Drugs"},{"key":"10.5604\/16652681.1231585_bib0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Disease"},{"key":"10.5604\/16652681.1231585_bib0090","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1231585_bib0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.510290145","article-title":"Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials","volume":"29","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1231585_bib0100","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1053\/j.gastro.2004.09.032","article-title":"Chemoembolization for hepatocel-lular carcinoma","volume":"127","author":"Bruix","year":"2004","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1231585_bib0105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2217\/fon.13.11","article-title":"Sorafenib in combination with transarterial chemoemboli-zation in Chinese patients with hepatocellular carcinoma: a subgroup interim analysis of the START trial","volume":"9","author":"Han","year":"2013","journal-title":"Future Oncol"},{"key":"10.5604\/16652681.1231585_bib0110","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/ijc.27925","article-title":"Interim analysis of START study: Study of Asia of the combination of TACE (transcatheter arterial chemoem-bolisation) with sorafenib in patients with hepatocellular carcinoma trial","volume":"132","author":"Chung","year":"2013","journal-title":"Int J Cancer"},{"key":"10.5604\/16652681.1231585_bib0115","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12885-015-1373-z","article-title":"Impact of neo-adjuvant soraf-enib treatment on liver transplantation in HCC patients- a prospective randomized double blind, phase III trial","volume":"15","author":"Hoffmann","year":"2015","journal-title":"BMC Cancer"},{"issue":"5","key":"10.5604\/16652681.1231585_bib0120","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2016.01.012","article-title":"Sorafenib or placebo plus TACE with doxoru-bicin- eluting beads for intermediate HCC: The SPACE trial","volume":"64","author":"Lencioni","year":"2016","journal-title":"J Hepatol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119303886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119303886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/publisherspanel.com\/icid\/pdf\/1231585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:34:39Z","timestamp":1761647679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119303886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1665268119303886"],"URL":"https:\/\/doi.org\/10.5604\/16652681.1231585","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B\/C of Hepatocellular Carcinoma: A Single Centre Experience","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.5604\/16652681.1231585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}